Cargando…
Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes
Type 1 diabetes mellitus (T1D) results from the destruction of insulin-producing β cells in the islet of the pancreas by lymphocytes. Non-obese diabetic (NOD) mouse is an animal model frequently used for this disease. It has been considered that T1D is a T cell-mediated autoimmune disease. Both CD4+...
Autores principales: | Lin, Jeng-Rong, Huang, Shing-Hwa, Wu, Chih-Hsiung, Chen, Yuan-Wu, Hong, Zhi-Jie, Cheng, Chia-Pi, Sytwu, Huey-Kang, Lin, Gu-Jiun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157191/ https://www.ncbi.nlm.nih.gov/pubmed/34067829 http://dx.doi.org/10.3390/ph14050475 |
Ejemplares similares
-
Genetically Engineered Islets and Alternative Sources of Insulin-Producing Cells for Treating Autoimmune Diabetes: Quo Vadis?
por: Chou, Feng-Cheng, et al.
Publicado: (2012) -
Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression
por: Lin, Gu-Jiun, et al.
Publicado: (2015) -
Modulation by Melatonin of the Pathogenesis of Inflammatory Autoimmune Diseases
por: Lin, Gu-Jiun, et al.
Publicado: (2013) -
Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes
por: Huang, Shing-Hwa, et al.
Publicado: (2022) -
Follicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft Rejection
por: Jeon, Yun-Hui, et al.
Publicado: (2016)